Showing results (11-20 of 84) with videos related to
Sort By:
Pageof 9
Clinical Pharmacokinetics|November 27, 2012
Pharmacodynamic models for discrete dataInes Paule, Pascal Girard, Gilles Freyer, et al.CPT: Pharmacometrics & Systems Pharmacology|October 20, 2020
Comparison of Various Phase I Combination Therapy Designs in Oncology for Evaluation of Early Tumor Shrinkage Using SimulationsJérémy Seurat, Pascal Girard, Kosalaram Goteti, et al.Neurobiology of Aging|November 5, 2018
Key periods of cognitive decline in a nonhuman primate model of cognitive aging, the common marmoset (Callithrix jacchus)Amirouche Sadoun, Maxime Rosito, Caroline Fonta, et al.Clinical and Translational Science|September 27, 2022
Population pharmacokinetic and pharmacodynamic modeling of evobrutinib in healthy adult participantsOrestis Papasouliotis, David Mitchell, Pascal Girard, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2003
Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectorisSylvie Chabaud, Pascal Girard, Patrice Nony, et al.Contemporary Clinical Trials|December 26, 2021
Optimization of dose selection using multiple surrogates of toxicity as a continuous variable in phase I cancer trialSe Yoon Lee, Alain Munafo, Pascal Girard, et al.Journal of Vision|July 24, 2024
Illusory light drives pupil responses in primatesJean-Baptiste Durand, Sarah Marchand, Ilyas Nasres, et al.Clinical and Translational Science|September 20, 2022
Determination of a clinically effective evobrutinib dose: Exposure-response analyses of a phase II relapsing multiple sclerosis studyOrestis Papasouliotis, David Mitchell, Pascal Girard, et al.CPT: Pharmacometrics & Systems Pharmacology|February 2, 2018
Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL MethodologyNadia Terranova, Pascal Girard, Konstantinos Ioannou, et al.Therapie|June 22, 2007
[Issues of the study of patient compliance to treatment with oral anticancer chemotherapy: advantages of pharmacokinetics-pharmacodynamics modelisation]Emilie Hénin, Benoit You, Brigitte Tranchand, et al.Pageof 9